SEC Form 4 · accession 0001209191-16-126253
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Pamela G Marrone
Officer — CEO and President · Director
Period of report
Jun 6, 2016
Accepted (ET)
Jun 7, 2016 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 6, 2016 | M | 5,000 | $0.692 | A | 790,309 | D | |
| Common Stock | holding | — | — | — | 53,134 | I | Jointly with Spouse | |
| Common StockF1 | holding | — | — | — | 6,442 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.